 | • レポートコード：MRC2312MG03870 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の鳥痘ワクチン市場規模と予測を収録しています。・世界の鳥痘ワクチン市場：売上、2018年-2023年、2024年-2029年 ・世界の鳥痘ワクチン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の鳥痘ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「水痘ワクチン水痘弱毒化ウイルスワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 鳥痘ワクチンのグローバル主要企業は、Boehringer-Ingelheim、 Living BP、 Zoetis、 Bio-Med、 MSD Animal Health、 HIPRA、 Vetvaco、 KBNP、 Hygieia、 Agrikhub、 Harbin Pharmaceutical Group、 Shandong Lvdu、 Zhejiang Nuobeiweiなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、鳥痘ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の鳥痘ワクチン市場：タイプ別、2018年-2023年、2024年-2029年 世界の鳥痘ワクチン市場：タイプ別市場シェア、2022年 ・水痘ワクチン水痘弱毒化ウイルスワクチン、水痘タンパク質グルテン弱毒化ワクチン（鶏痘オリジナル）、水痘タンパク質グルテン弱毒化ワクチン（ハト痘由来） 世界の鳥痘ワクチン市場：用途別、2018年-2023年、2024年-2029年 世界の鳥痘ワクチン市場：用途別市場シェア、2022年 ・鶏肉、成鶏 世界の鳥痘ワクチン市場：地域・国別、2018年-2023年、2024年-2029年 世界の鳥痘ワクチン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における鳥痘ワクチンのグローバル売上、2018年-2023年 ・主要企業における鳥痘ワクチンのグローバル売上シェア、2022年 ・主要企業における鳥痘ワクチンのグローバル販売量、2018年-2023年 ・主要企業における鳥痘ワクチンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Boehringer-Ingelheim、 Living BP、 Zoetis、 Bio-Med、 MSD Animal Health、 HIPRA、 Vetvaco、 KBNP、 Hygieia、 Agrikhub、 Harbin Pharmaceutical Group、 Shandong Lvdu、 Zhejiang Nuobeiwei ************************************************************* ・調査・分析レポートの概要 鳥痘ワクチン市場の定義 市場セグメント 世界の鳥痘ワクチン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の鳥痘ワクチン市場規模 世界の鳥痘ワクチン市場規模：2022年 VS 2029年 世界の鳥痘ワクチン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの鳥痘ワクチンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の鳥痘ワクチン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：水痘ワクチン水痘弱毒化ウイルスワクチン、水痘タンパク質グルテン弱毒化ワクチン（鶏痘オリジナル）、水痘タンパク質グルテン弱毒化ワクチン（ハト痘由来） 鳥痘ワクチンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：鶏肉、成鶏 鳥痘ワクチンの用途別グローバル売上・予測 ・地域別市場分析 地域別鳥痘ワクチン市場規模 2022年と2029年 地域別鳥痘ワクチン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Boehringer-Ingelheim、 Living BP、 Zoetis、 Bio-Med、 MSD Animal Health、 HIPRA、 Vetvaco、 KBNP、 Hygieia、 Agrikhub、 Harbin Pharmaceutical Group、 Shandong Lvdu、 Zhejiang Nuobeiwei ... |
This research report provides a comprehensive analysis of the Avian Pox Vaccine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Avian Pox Vaccine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Avian Pox Vaccine, challenges faced by the industry, and potential opportunities for market players.
The global Avian Pox Vaccine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Avian Pox Vaccine market presents opportunities for various stakeholders, including Chicken, Adult Chicken. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Avian Pox Vaccine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Avian Pox Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Avian Pox Vaccine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Avian Pox Vaccine market.
Market Overview: The report provides a comprehensive overview of the Avian Pox Vaccine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Chicken Pox Vaccine Chicken Pox Quailized Attenuated Virus Vaccine, Chickenpox Protein Gluten Attenuated Vaccine (Fowlpox Original)), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Avian Pox Vaccine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Avian Pox Vaccine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Avian Pox Vaccine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Avian Pox Vaccine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Avian Pox Vaccine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Avian Pox Vaccine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Avian Pox Vaccine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Avian Pox Vaccine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Avian Pox Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chicken Pox Vaccine Chicken Pox Quailized Attenuated Virus Vaccine
Chickenpox Protein Gluten Attenuated Vaccine (Fowlpox Original)
Chicken Pox Protein Gluten Attenuated Vaccine (Pigeon Pox Origin)
Market segment by Application
Chicken
Adult Chicken
Global Avian Pox Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Boehringer-Ingelheim
Living BP
Zoetis
Bio-Med
MSD Animal Health
HIPRA
Vetvaco
KBNP
Hygieia
Agrikhub
Harbin Pharmaceutical Group
Shandong Lvdu
Zhejiang Nuobeiwei
Outline of Major Chapters:
Chapter 1: Introduces the definition of Avian Pox Vaccine, market overview.
Chapter 2: Global Avian Pox Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Avian Pox Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Avian Pox Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Avian Pox Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Avian Pox Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Avian Pox Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Avian Pox Vaccine Overall Market Size
2.1 Global Avian Pox Vaccine Market Size: 2022 VS 2029
2.2 Global Avian Pox Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Avian Pox Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Avian Pox Vaccine Players in Global Market
3.2 Top Global Avian Pox Vaccine Companies Ranked by Revenue
3.3 Global Avian Pox Vaccine Revenue by Companies
3.4 Global Avian Pox Vaccine Sales by Companies
3.5 Global Avian Pox Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Avian Pox Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Avian Pox Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Avian Pox Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Avian Pox Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Avian Pox Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Avian Pox Vaccine Market Size Markets, 2022 & 2029
4.1.2 Chicken Pox Vaccine Chicken Pox Quailized Attenuated Virus Vaccine
4.1.3 Chickenpox Protein Gluten Attenuated Vaccine (Fowlpox Original)
4.1.4 Chicken Pox Protein Gluten Attenuated Vaccine (Pigeon Pox Origin)
4.2 By Type – Global Avian Pox Vaccine Revenue & Forecasts
4.2.1 By Type – Global Avian Pox Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Avian Pox Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Avian Pox Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Avian Pox Vaccine Sales & Forecasts
4.3.1 By Type – Global Avian Pox Vaccine Sales, 2018-2023
4.3.2 By Type – Global Avian Pox Vaccine Sales, 2024-2029
4.3.3 By Type – Global Avian Pox Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Avian Pox Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Avian Pox Vaccine Market Size, 2022 & 2029
5.1.2 Chicken
5.1.3 Adult Chicken
5.2 By Application – Global Avian Pox Vaccine Revenue & Forecasts
5.2.1 By Application – Global Avian Pox Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Avian Pox Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Avian Pox Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Avian Pox Vaccine Sales & Forecasts
5.3.1 By Application – Global Avian Pox Vaccine Sales, 2018-2023
5.3.2 By Application – Global Avian Pox Vaccine Sales, 2024-2029
5.3.3 By Application – Global Avian Pox Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Avian Pox Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Avian Pox Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Avian Pox Vaccine Revenue & Forecasts
6.2.1 By Region – Global Avian Pox Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Avian Pox Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Avian Pox Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Avian Pox Vaccine Sales & Forecasts
6.3.1 By Region – Global Avian Pox Vaccine Sales, 2018-2023
6.3.2 By Region – Global Avian Pox Vaccine Sales, 2024-2029
6.3.3 By Region – Global Avian Pox Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Avian Pox Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Avian Pox Vaccine Sales, 2018-2029
6.4.3 US Avian Pox Vaccine Market Size, 2018-2029
6.4.4 Canada Avian Pox Vaccine Market Size, 2018-2029
6.4.5 Mexico Avian Pox Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Avian Pox Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Avian Pox Vaccine Sales, 2018-2029
6.5.3 Germany Avian Pox Vaccine Market Size, 2018-2029
6.5.4 France Avian Pox Vaccine Market Size, 2018-2029
6.5.5 U.K. Avian Pox Vaccine Market Size, 2018-2029
6.5.6 Italy Avian Pox Vaccine Market Size, 2018-2029
6.5.7 Russia Avian Pox Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Avian Pox Vaccine Market Size, 2018-2029
6.5.9 Benelux Avian Pox Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Avian Pox Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Avian Pox Vaccine Sales, 2018-2029
6.6.3 China Avian Pox Vaccine Market Size, 2018-2029
6.6.4 Japan Avian Pox Vaccine Market Size, 2018-2029
6.6.5 South Korea Avian Pox Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Avian Pox Vaccine Market Size, 2018-2029
6.6.7 India Avian Pox Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Avian Pox Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Avian Pox Vaccine Sales, 2018-2029
6.7.3 Brazil Avian Pox Vaccine Market Size, 2018-2029
6.7.4 Argentina Avian Pox Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Avian Pox Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Avian Pox Vaccine Sales, 2018-2029
6.8.3 Turkey Avian Pox Vaccine Market Size, 2018-2029
6.8.4 Israel Avian Pox Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Avian Pox Vaccine Market Size, 2018-2029
6.8.6 UAE Avian Pox Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Boehringer-Ingelheim
7.1.1 Boehringer-Ingelheim Company Summary
7.1.2 Boehringer-Ingelheim Business Overview
7.1.3 Boehringer-Ingelheim Avian Pox Vaccine Major Product Offerings
7.1.4 Boehringer-Ingelheim Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Boehringer-Ingelheim Key News & Latest Developments
7.2 Living BP
7.2.1 Living BP Company Summary
7.2.2 Living BP Business Overview
7.2.3 Living BP Avian Pox Vaccine Major Product Offerings
7.2.4 Living BP Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Living BP Key News & Latest Developments
7.3 Zoetis
7.3.1 Zoetis Company Summary
7.3.2 Zoetis Business Overview
7.3.3 Zoetis Avian Pox Vaccine Major Product Offerings
7.3.4 Zoetis Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Zoetis Key News & Latest Developments
7.4 Bio-Med
7.4.1 Bio-Med Company Summary
7.4.2 Bio-Med Business Overview
7.4.3 Bio-Med Avian Pox Vaccine Major Product Offerings
7.4.4 Bio-Med Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Bio-Med Key News & Latest Developments
7.5 MSD Animal Health
7.5.1 MSD Animal Health Company Summary
7.5.2 MSD Animal Health Business Overview
7.5.3 MSD Animal Health Avian Pox Vaccine Major Product Offerings
7.5.4 MSD Animal Health Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 MSD Animal Health Key News & Latest Developments
7.6 HIPRA
7.6.1 HIPRA Company Summary
7.6.2 HIPRA Business Overview
7.6.3 HIPRA Avian Pox Vaccine Major Product Offerings
7.6.4 HIPRA Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 HIPRA Key News & Latest Developments
7.7 Vetvaco
7.7.1 Vetvaco Company Summary
7.7.2 Vetvaco Business Overview
7.7.3 Vetvaco Avian Pox Vaccine Major Product Offerings
7.7.4 Vetvaco Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Vetvaco Key News & Latest Developments
7.8 KBNP
7.8.1 KBNP Company Summary
7.8.2 KBNP Business Overview
7.8.3 KBNP Avian Pox Vaccine Major Product Offerings
7.8.4 KBNP Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 KBNP Key News & Latest Developments
7.9 Hygieia
7.9.1 Hygieia Company Summary
7.9.2 Hygieia Business Overview
7.9.3 Hygieia Avian Pox Vaccine Major Product Offerings
7.9.4 Hygieia Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Hygieia Key News & Latest Developments
7.10 Agrikhub
7.10.1 Agrikhub Company Summary
7.10.2 Agrikhub Business Overview
7.10.3 Agrikhub Avian Pox Vaccine Major Product Offerings
7.10.4 Agrikhub Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Agrikhub Key News & Latest Developments
7.11 Harbin Pharmaceutical Group
7.11.1 Harbin Pharmaceutical Group Company Summary
7.11.2 Harbin Pharmaceutical Group Business Overview
7.11.3 Harbin Pharmaceutical Group Avian Pox Vaccine Major Product Offerings
7.11.4 Harbin Pharmaceutical Group Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Harbin Pharmaceutical Group Key News & Latest Developments
7.12 Shandong Lvdu
7.12.1 Shandong Lvdu Company Summary
7.12.2 Shandong Lvdu Business Overview
7.12.3 Shandong Lvdu Avian Pox Vaccine Major Product Offerings
7.12.4 Shandong Lvdu Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Shandong Lvdu Key News & Latest Developments
7.13 Zhejiang Nuobeiwei
7.13.1 Zhejiang Nuobeiwei Company Summary
7.13.2 Zhejiang Nuobeiwei Business Overview
7.13.3 Zhejiang Nuobeiwei Avian Pox Vaccine Major Product Offerings
7.13.4 Zhejiang Nuobeiwei Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Zhejiang Nuobeiwei Key News & Latest Developments
8 Global Avian Pox Vaccine Production Capacity, Analysis
8.1 Global Avian Pox Vaccine Production Capacity, 2018-2029
8.2 Avian Pox Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Avian Pox Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Avian Pox Vaccine Supply Chain Analysis
10.1 Avian Pox Vaccine Industry Value Chain
10.2 Avian Pox Vaccine Upstream Market
10.3 Avian Pox Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Avian Pox Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer